Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium falciparum is a protozoan parasite and the most virulent species causing malaria in humans. The blood stage of P. falciparum refers to the phase of its life cycle when it infects human red blood cells (RBCs), leading to clinical symptoms and transmission potential. The parasite undergoes a 48-hour intraerythrocytic developmental cycle and can modify host RBC surfaces, leading to cytoadherence and sequestration in capillaries. Key features include ring forms, high-grade parasitemia, and crescent/banana-shaped gametocytes.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum (blood stage) (P. falciparum (blood stage)).